Matches in SemOpenAlex for { <https://semopenalex.org/work/W2984363909> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W2984363909 endingPage "107697" @default.
- W2984363909 startingPage "107697" @default.
- W2984363909 abstract "A sustained-release formulation (SRF) of tapentadol has been marketed in Australia since February 2013. This study examined tapentadol SRF extra-medical use, attractiveness for extra-medical use, and associated harms in Australia.This post-marketing study comprises analyses of Australian community sales data (2011-2017) for eleven pharmaceutical opioids (prescription and over-the-counter codeine disaggregated); calls to three poisons information centres (covering five of the eight jurisdictions in Australia) related to pharmaceutical opioids and coded by the centres as 'misuse' or 'abuse' (2011-2017); and interviews with people who inject drugs (n = 888) recruited as part of the Illicit Drug Reporting System (IDRS) from all Australian capital cities (2017).Population-level availability of tapentadol SRF increased from market launch, comprising the sixth largest market share of all opioid unit sales, and third greatest share in oral morphine equivalent milligrams sold, in December 2017. Lifetime tapentadol SRF use among the IDRS sample (n = 888) was low (1.5%; 95%CI 0.9-2.5), with few reporting past-6 month non-prescribed use or injection. Non-fatal overdose following tapentadol use was self-reported by less than 1% (95%CI 0.1-0.8). Between 2013-2017, 1.1% (n = 25) of pharmaceutical opioid 'misuse/abuse' calls were related to tapentadol, and predominantly the SRF.Increasing utilisation of tapentadol sustained-release formulation was observed, along with indications of extra-medical use and harms associated with use, although on a smaller scale relative to other opioids. These findings need to be interpreted in the context of the low level of exposure to tapentadol sustained-release formulation among the sentinel population of people who inject drugs." @default.
- W2984363909 created "2019-11-22" @default.
- W2984363909 creator A5007290128 @default.
- W2984363909 creator A5034739281 @default.
- W2984363909 creator A5035152541 @default.
- W2984363909 creator A5037681212 @default.
- W2984363909 creator A5040371388 @default.
- W2984363909 creator A5041340005 @default.
- W2984363909 creator A5052675833 @default.
- W2984363909 creator A5060125444 @default.
- W2984363909 creator A5078637043 @default.
- W2984363909 date "2020-01-01" @default.
- W2984363909 modified "2023-10-16" @default.
- W2984363909 title "Opioid use and harms associated with a sustained-release tapentadol formulation: A post-marketing surveillance study" @default.
- W2984363909 cites W1524044784 @default.
- W2984363909 cites W1564287406 @default.
- W2984363909 cites W1929010380 @default.
- W2984363909 cites W2014051345 @default.
- W2984363909 cites W2016375172 @default.
- W2984363909 cites W2036267079 @default.
- W2984363909 cites W2045707303 @default.
- W2984363909 cites W2087628574 @default.
- W2984363909 cites W2114341681 @default.
- W2984363909 cites W2115107257 @default.
- W2984363909 cites W2158017724 @default.
- W2984363909 cites W2160842604 @default.
- W2984363909 cites W2233361447 @default.
- W2984363909 cites W2282597098 @default.
- W2984363909 cites W2300421333 @default.
- W2984363909 cites W2772574650 @default.
- W2984363909 cites W2783726333 @default.
- W2984363909 cites W2789298338 @default.
- W2984363909 cites W2799570263 @default.
- W2984363909 doi "https://doi.org/10.1016/j.drugalcdep.2019.107697" @default.
- W2984363909 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31869601" @default.
- W2984363909 hasPublicationYear "2020" @default.
- W2984363909 type Work @default.
- W2984363909 sameAs 2984363909 @default.
- W2984363909 citedByCount "9" @default.
- W2984363909 countsByYear W29843639092020 @default.
- W2984363909 countsByYear W29843639092022 @default.
- W2984363909 countsByYear W29843639092023 @default.
- W2984363909 crossrefType "journal-article" @default.
- W2984363909 hasAuthorship W2984363909A5007290128 @default.
- W2984363909 hasAuthorship W2984363909A5034739281 @default.
- W2984363909 hasAuthorship W2984363909A5035152541 @default.
- W2984363909 hasAuthorship W2984363909A5037681212 @default.
- W2984363909 hasAuthorship W2984363909A5040371388 @default.
- W2984363909 hasAuthorship W2984363909A5041340005 @default.
- W2984363909 hasAuthorship W2984363909A5052675833 @default.
- W2984363909 hasAuthorship W2984363909A5060125444 @default.
- W2984363909 hasAuthorship W2984363909A5078637043 @default.
- W2984363909 hasConcept C126322002 @default.
- W2984363909 hasConcept C144133560 @default.
- W2984363909 hasConcept C166957645 @default.
- W2984363909 hasConcept C170493617 @default.
- W2984363909 hasConcept C205649164 @default.
- W2984363909 hasConcept C2426938 @default.
- W2984363909 hasConcept C2776029756 @default.
- W2984363909 hasConcept C2779343474 @default.
- W2984363909 hasConcept C2780505013 @default.
- W2984363909 hasConcept C2781063702 @default.
- W2984363909 hasConcept C512399662 @default.
- W2984363909 hasConcept C71924100 @default.
- W2984363909 hasConcept C98274493 @default.
- W2984363909 hasConceptScore W2984363909C126322002 @default.
- W2984363909 hasConceptScore W2984363909C144133560 @default.
- W2984363909 hasConceptScore W2984363909C166957645 @default.
- W2984363909 hasConceptScore W2984363909C170493617 @default.
- W2984363909 hasConceptScore W2984363909C205649164 @default.
- W2984363909 hasConceptScore W2984363909C2426938 @default.
- W2984363909 hasConceptScore W2984363909C2776029756 @default.
- W2984363909 hasConceptScore W2984363909C2779343474 @default.
- W2984363909 hasConceptScore W2984363909C2780505013 @default.
- W2984363909 hasConceptScore W2984363909C2781063702 @default.
- W2984363909 hasConceptScore W2984363909C512399662 @default.
- W2984363909 hasConceptScore W2984363909C71924100 @default.
- W2984363909 hasConceptScore W2984363909C98274493 @default.
- W2984363909 hasFunder F4320322220 @default.
- W2984363909 hasLocation W29843639091 @default.
- W2984363909 hasLocation W29843639092 @default.
- W2984363909 hasOpenAccess W2984363909 @default.
- W2984363909 hasPrimaryLocation W29843639091 @default.
- W2984363909 hasRelatedWork W1995188972 @default.
- W2984363909 hasRelatedWork W2036825593 @default.
- W2984363909 hasRelatedWork W2419144289 @default.
- W2984363909 hasRelatedWork W2912718090 @default.
- W2984363909 hasRelatedWork W3196844646 @default.
- W2984363909 hasRelatedWork W4205826189 @default.
- W2984363909 hasRelatedWork W4224059672 @default.
- W2984363909 hasRelatedWork W4225538511 @default.
- W2984363909 hasRelatedWork W4312018447 @default.
- W2984363909 hasRelatedWork W4318671286 @default.
- W2984363909 hasVolume "206" @default.
- W2984363909 isParatext "false" @default.
- W2984363909 isRetracted "false" @default.
- W2984363909 magId "2984363909" @default.
- W2984363909 workType "article" @default.